Jane Street’s Endovia Health Sciences, Inc. EDVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$54K Buy
+87,105
New +$90.2K ﹤0.01% 10897
2025
Q1
Sell
-527
Closed -$13.6K 10457
2024
Q4
$13.6K Buy
527
+291
+123% +$9.64K ﹤0.01% 9160
2024
Q3
$9.52K Buy
236
+164
+228% +$8.26K ﹤0.01% 9358
2024
Q2
$2.67K Buy
+72
New +$3.38K ﹤0.01% 9195
2024
Q1
Sell
-128
Closed -$11.3K 9976
2023
Q4
$11.3K Buy
128
+43
+51% +$4.09K ﹤0.01% 8957
2023
Q3
$8.03K Buy
+85
New +$11K ﹤0.01% 8404
2021
Q4
Sell
-139
Closed -$44K 10731
2021
Q3
$44K Buy
+139
New +$62.8K ﹤0.01% 9582

Other funds holding EDVA

Jane Street's EDVA Position: Q2 2026 in Review

Jane Street opened a new position in Endovia Health Sciences, Inc. (EDVA) in Q2 2026: 87,105 shares worth $54K. The stake represents ﹤0.01% of the portfolio and ranks #10897 among its holdings. This is a return to the name: Jane Street previously reported a position in EDVA as recently as Q4 2024.

Jane Street first reported a position in EDVA in Q3 2021 and has held it in 7 quarters since. 18 funds tracked by Wall St. Rank hold EDVA as of Q2 2026.

  • Jane Street held 87,105 shares of Endovia Health Sciences, Inc. worth $54K as of Q2 2026.
  • Endovia Health Sciences, Inc. was a new Jane Street position in Q2 2026.
  • Endovia Health Sciences, Inc. made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #10897 holding.
  • Jane Street first reported a position in Endovia Health Sciences, Inc. in Q3 2021 and has held it in 7 quarters since.
  • 18 funds tracked by Wall St. Rank held Endovia Health Sciences, Inc. as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.